Divi's Laboratories Limited has submitted a regulatory disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure announces the schedule for the company's earnings conference call following the release of its unaudited financial results for the quarter and half year ended September 30, 2026 (Q2FY27).
The earnings conference call is scheduled to be held on November 07, 2026, at 14:00 hours IST. The management of the company will host the call to discuss the company's financial performance for the specified period.
Conference Call Access Details
Participants can join the earnings conference call through two options:
Option 1: Express Join with DiamondPass™
- Pre-registration available via provided link: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=3977234&linkSecurityString=238ccbab4c
Option 2: Direct Dial-In Numbers
- Universal Dial-In: +91 22 6280 1526
- Universal Dial-In: +91 22 7115 8341
Participants are advised to dial in approximately five minutes before the scheduled start time. The operator will provide instructions for asking questions during the call.
Additional Information
A transcript of the conference call will be made available on the company's official website at www.divislabs.com post-event.
For further information, investors can contact the Investor Relations team at:
- Mobile: +91 91542 18881
The disclosure was signed by M. Satish Choudhury, Company Secretary & Compliance Officer of Divi's Laboratories Limited, and submitted to both the National Stock Exchange of India Limited and BSE Limited.